BioLife Capital Surpluse from 2010 to 2024
| BLFS Stock | USD 27.06 0.29 1.08% |
Capital Surpluse | First Reported 2011-06-30 | Previous Quarter 619.2 M | Current Value 623.4 M | Quarterly Volatility 190.2 M |
Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 1.9 M, Selling General Administrative of 52.9 M or Total Revenue of 150.4 M, as well as many indicators such as Price To Sales Ratio of 4.71, Dividend Yield of 0.0014 or PTB Ratio of 2.0. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
BioLife | Capital Surpluse |
Latest BioLife Solutions' Capital Surpluse Growth Pattern
Below is the plot of the Capital Surpluse of BioLife Solutions over the last few years. It is BioLife Solutions' Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.
| Capital Surpluse | 10 Years Trend |
|
Capital Surpluse |
| Timeline |
BioLife Capital Surpluse Regression Statistics
| Arithmetic Mean | 156,974,487 | |
| Geometric Mean | 113,357,252 | |
| Coefficient Of Variation | 80.55 | |
| Mean Deviation | 111,506,180 | |
| Median | 84,036,444 | |
| Standard Deviation | 126,441,814 | |
| Sample Variance | 15987.5T | |
| Range | 322.5M | |
| R-Value | 0.92 | |
| Mean Square Error | 2602.3T | |
| R-Squared | 0.85 | |
| Slope | 26,049,059 | |
| Total Sum of Squares | 223825.5T |
BioLife Capital Surpluse History
About BioLife Solutions Financial Statements
BioLife Solutions shareholders use historical fundamental indicators, such as Capital Surpluse, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Capital Surpluse | 348 M | 365.4 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.